Grammy winner Meghan Trainor included a "shoutout" to Mounjaro, which she used "to help me after my 2nd pregnancy. And I'm so ...

The EU medicines regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's ability to slow cognitive ...

With expertise in pharmaceutical supply chains and medical technology, healthcare CEO and entrepreneur Dr. Jay Bhaumik has ...

The Hatch Waxman Act and the Biological Price Competition and Innovation Act have incentivized efforts to improperly prolong ...

The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug ...

A growing concern in Japan, but there is something new on the horizon. | Japan faces a growing "Drug Loss" issue, but ...

Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds ...

Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.

Alzheimer's disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited ...

With the CSF-1R inhibitor space heating up, Germany's Merck Group has gone all-in on pimicotinib, paying Abbisko Therapeutics ...

Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.